Funding Rounds
MinervaX Series B (2020, $57M)
MinervaXDeveloper of prophylactic vaccine against Group B Streptococcus.
Summary
Stage: Series B
Raised Amount: $57.97M
Raised Date: 2020-01-01
Stage: Series B
Raised Amount: $57.97M
Raised Date: 2020-01-01
